Making the Blind See with Ultrasensitive Algal Photoreceptors
Professor Sukhdev Roy's team used theoretical modelling to predict that the light-sensitive protein ChRmine and its variants could drive optogenetic vision restoration under ordinary ambient and broadband light.
Read the original paper
Vision restoration for individuals affected by retinal degeneration has taken a promising leap forward, thanks to advancements in optogenetics. Researchers Dr. Himanshu Bansal and Gur Pyari, led by Professor Sukhdev Roy from the Dayalbagh Educational Institute, Agra, India, have conducted a detailed theoretical study showing how light-sensitive proteins called channelrhodopsins, which act as light detectors in cells, especially ChRmine, the novel red-shifted opsin and its specially designed variants, can help restore vision under ambient lighting conditions. The study, published in Scientific Reports, offers insights into vision-restoration that does not require any bulky goggles, making life easier for millions of people.
The research examines the challenges of restoring vision using optogenetics, a technology that uses light-sensitive proteins to activate nerve cells in the retina, which is the light-sensitive layer of tissue at the back of the eye. Traditional methods faced issues such as requiring very bright light, working only within a limited range of light colors, and reacting too slowly to changes in light. The first successful human clinical trial of optogenetic therapy on a blind patient was reported in the journal Nature Medicine in 2021. Visual function could be partially restored with the use of specially designed goggles that could detect local changes in light intensity and project appropriate light pulses onto the retina in real time, to trigger optogenetically transduced retinal ganglion cells using ChrimsonR opsin. The present study marks a significant improvement and highlights how ChRmine with improved light sensitivity and robustness to elicit action potentials, can function effectively in everyday lighting, such as sunlight and white light, using much less light than earlier methods. This breakthrough marks a big improvement in making the process more natural and user-friendly.
One of the most remarkable discoveries is ChRmine’s ability to activate nerve cells with extremely low levels of light, i.e., the amount of light required is minimal. These levels are much lower than the brightness of a cloudy day. This means that devices using ChRmine could work without needing extra artificial lighting, which is often inconvenient and uncomfortable for users. Professor Roy noted, “This marks a significant change in optogenetics, as we can now work towards integrating natural light conditions into devices that help restore vision.”
The researchers also studied improved versions of ChRmine, including hsChRmine, a faster-acting variant called the high-speed ChRmine mutant. This version reacts quicker and can work across a broader range of light colors. While ChRmine can stimulate nerve cells to fire signals, which are the messages sent by neurons, at a speed similar to natural processes, the high-speed variant can do this almost twice as fast, improving the quality of vision restoration. These features are essential for helping individuals regain the ability to see colors and movement more clearly.
The study’s simulations also showed that using light with a mix of wavelengths—a range of colors, like the light found in natural sunlight—offers significant benefits compared to devices that rely on narrow bands of light, such as light-emitting diodes, which produce light of a specific color. ChRmine responded much more strongly to this type of mixed light, creating several times the response compared to other methods. Professor Roy explained, “Using light that spans a wider range of colors is a major advancement. It helps us achieve high-quality vision restoration while using much lower light levels, which keeps the eye safe from heating and photodamage and reduces dependence on artificial lighting.”
In summary, Professor Roy’s study not only highlights ChRmine’s potential for vision restoration without invasive surgery, which means no need for major operations, but also points to exciting possibilities for future developments in optogenetics. By combining high sensitivity to light intensity and color, quick reactions, improved quality and the ability to work with natural lighting, ChRmine and its improved versions could transform treatments for people with vision loss. The findings represent an important step toward creating affordable and effective optogenetic retinal prostheses that improve the quality of life for those with visual impairments.
About the researchers
Journal reference
Himanshu Bansal, Gur Pyari and Sukhdev Roy, “Theoretical prediction of broadband ambient light optogenetic vision restoration with ChRmine and its mutants.” Scientific Reports, 2024. DOI: https://doi.org/10.1038/s41598-024-62558-2





